Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Goodwill (2020 - 2023)

Historic Goodwill for Insight Molecular Diagnostics (IMDX) over the last 4 years, with Q3 2023 value amounting to $9.5 million.

  • Insight Molecular Diagnostics' Goodwill fell 4915.44% to $9.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.5 million, marking a year-over-year decrease of 4915.44%. This contributed to the annual value of $9.5 million for FY2022, which is 4915.44% down from last year.
  • According to the latest figures from Q3 2023, Insight Molecular Diagnostics' Goodwill is $9.5 million, which was down 4915.44% from $9.5 million recorded in Q2 2023.
  • Insight Molecular Diagnostics' 5-year Goodwill high stood at $24.2 million for Q2 2021, and its period low was $9.2 million during Q1 2020.
  • Moreover, its 4-year median value for Goodwill was $9.5 million (2022), whereas its average is $13.0 million.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Goodwill skyrocketed by 16381.84% in 2021 and then crashed by 4915.44% in 2022.
  • Over the past 4 years, Insight Molecular Diagnostics' Goodwill (Quarter) stood at $9.2 million in 2020, then surged by 103.37% to $18.7 million in 2021, then crashed by 49.15% to $9.5 million in 2022, then changed by 0.0% to $9.5 million in 2023.
  • Its last three reported values are $9.5 million in Q3 2023, $9.5 million for Q2 2023, and $9.5 million during Q1 2023.